Haematology Flashcards
(167 cards)
Malaria
a parasitic infection caused by protozoa of the genus plasmodium, this infection is almost exclusively sen in tropics & subtropics
Notifiable disease in the UK
NB consider malaria in every febrile travel returning from a malaria endemic area in the last year
Protective factors for malaria
sickle cell trait
G6PD deficiency
HLA-B53
Species of malaria
Plasmodium falciparum
- commonest type
- most severe kind
non falciparum (plasmodium vivax/ovale/malarine)
- plasmodium vivax is most common
- vivax is usually benign
Presentation of malaria
fever
- often recurring
- cyclical, occurring every 48-72h
chills, rigors, headache, cough, myalgia, GI upset
jaundice
hepato/splenomegaly
Severe disease (usually P. falciparum)
- impaired consciousness
- SOB
- bleeding
- fits
- AKI, ARDS, anaemia
Investigations for malaria
Blood smears with Giemsa stain
- gold standard
- presence of parasites within RBCs
FBC
- ↓Hb
- thrombocytopenia
- ↑ reticulocytes
Rapid diagnostic tests (RDIs)
-detect parasite antigens
LFTs
-often abnormal
Management of malaria
Falciparum:
- Artemisinin-based combination therapy (ART) or PO quinine if uncomplicated
- IV quinine in severe disease
Non-falciparum malaria:
- 1st line = chloroquine
- 2nd line = ART (1st line if chloroquine resistance)
- primaquine (as relapse prevention, destroys liver hypnozoites)
Prevention of malaria
reduced chance of being bitten
- misquito nets
- mosquito spray
Chemoprophylaxis
- start 1 week befogging entering malarious area
- chloroquine, proguanil, mefloquine
Hodgkin’s lymphoma
malignant tumour of the lymphatic system characterised histologically by the presence of Reed-Sternberg cells (multinucleate giant cells)
Bi-modal age distribution
- peak age 20-34yrs
- 2nd peak >70yrs
classical Hodgkin’s lymphoma (most common), especially nodular sclerosing kind
NB lymphocyte deplete kind is rare & carries worst prognosis
Risk factors include immunodeficiency, EBV infection & autoimmune disease
Hodgkin’s lymphoma characteristic histological feature
Reed-Sternberg cells (multinucleate giant cells)
Presentation of Hodgkin’s lymphoma
painless non tender asymmetrical lymphadenopathy
- most frequently affects cervical nodes
- may present as mediastinal mass
B symptoms
- weight loss, fever, night sweats
- imply poor prognosis
alcohol induced pain at sites of nodal disease
Investigations for Hodgkin’s lymphoma
FBC
- ↑/↓ WCC
- ↓Hb
- eosinophilia
Lymph node biopsy
- Reed-Sternberg cells
- Hodgkins cells
CXR
- mediastinal mass
- mediastinal lymphadenopathy
ESR (↑), LDH (↑)
CT, Gallium scan, PET-CT
Management of Hodgkin’s lymphoma
chemo+radiotherapy
-ABVD or BEACOPP regimes
autologous stem cell transplant
Non-Hodgkin’s lymphoma
a heterogenous group of malignancies of the lymphoid system, ~5x more common than Hodgkin’s lymphoma
usually seen in >50y/o pts
Subtypes
- B-cell lymphomas (~85%)
- T-cell lymphomas (~15%)
Risk factors include Caucasian origin, EBC infection, FH of lymphoma, immunodeficiency, autoimmune disease
Presentation of Non-Hodgkin’s lymphoma
painless lymphadenopathy
- non tender
- rubbery
- asymmetrical
constitutional/B-symptoms
-fever, weight loss, night sweats, lethargy
splenomegaly, hepatomegaly
Extra-nodal disease (more common than in Hodgkins)
-early satiety, GI bleeding, headache, skin lesions, pruritus
Investigations for Non-Hodgkin’s lymphoma
excision node biopsy
-investigation of choice
CT chest/abdo/pelvis
FBC (↓Hb), ESR (↑), LDH (↑)
PET-CT
Management of Non-Hodgkin’s lymphoma
depends on subtype
generally watch & wait (if low grade), chemo or radiotherapy
Burkitt’s lymphoma
high grade non-hodgkins lymphoma, that is rapidly growing & aggressive
usually seen in children, and is strongly associated with EBV infection
characterised by starry-sky appearance on biopsy (lymphocyte sheets interspersed with macrophages containing dead apoptotic tumour cells)
managed with chemo
Strongly associated with tumour lysis syndrome
Acute lymphoblastic leukaemia (ALL)
a malignant clonal disease that develops when lymphoid progenitor cells undergo uncontrolled proliferation
most common cancer in children with peak incidence at 2-5yrs
-~80% of leukemias in children)
Presentation of Acute lymphoblastic leukaemia (ALL)
sudden onset & rapid progression
fatigue dizziness, palpations, pallor, weakness
bone & joint pain
headache, neck stiffness
fever without obvious infection
bruising, epistaxis, petechiae, ecchymosis
LUQ fullness, early satiety (due to splenomegaly)
testicular enlargement
lymphadenopathy
Investigations for Acute lymphoblastic leukaemia (ALL)
FBC
- ↓ Hb
- ↓ platelets
- ↓ neutrophils
- ↓/↑WCC
Blood smear
-leukaemic lymphoblasts
Bone marrow aspiration &biopsy
-≥20% blast cells
clotting (may show DIC), LDH (↑), uric acid (↑)
LFTs, U&Es,
Management of Acute lymphoblastic leukaemia (ALL)
Induction (to restore normal haematopoesis)
-corticosteroids + vincristine/cyclophosphamide/doxorubicin
Maintenance
-mercaptopurine + methotrexate
CNS prophylaxis
-intrathecal methotrexate
Stem cell transplant
NB relapses after treatment have very poor prognosis
Acute myeloid leukaemia (AML)
the malignant clinical expansion of myeloid blasts in the bone marrow, peripheral blood or extra medullary tissue
may be primary disease or secondary transformation of other lymphoproliferative disorders
Most common acute leukaemia in adults usually seen age 65yrs
Risk factors for Acute myeloid leukaemia (AML)
aplastic anaemia
myelofibrosis
paroxysmal nocturnal haemoglobulinaemia
polycythaemia rubera vera
Presentation of Acute myeloid leukaemia (AML)
anaemia (pallor, fatigue, weakness) fever petechiae purpura ecchymosis epistaxis frequent infections hepatosplenomegaly leukaemia cutis (nodular skin lesions, gray-blue/purple) gingival hypertrophy gingivitis bleeding gums